// App-Quantinova.ai

BSH19‐OR‐034 : Parasite histones are associated with poor outcome in cerebral malaria

Researchers

Presenter

  • C. Moxon

Principal Investigators

  • Y. Alhamdi

  • J. Storm

  • J. Toh

  • J.Y. Ko

  • G. Murphy

  • T. Taylor

  • K. Seydel

  • G. Wang

  • G. Garca-Cardea

  • M. Molyneux

  • A. Craig

  • S. Abrams

  • C.-H. Toh

Medical Centers

  • Institute of Infection and Global Health, University of Liverpool, Liverpool,United Kingdom

  • Wellcome Centre for Molecular Parasitology, Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow

  • Liverpool School of Tropical Medicine, Liverpool, UK

  • Univ. of Sheffield Medical School, Sheffield, United Kingdom

  • Department of Urology, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine, Seoul, Korea, Republic of

  • Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

  • College of Veterinary Medicine, Michigan State University, East Lansing, United States

  • University of Malawi College of Medicine, Blantyre, Malawi

  • Malawi‐Liverpool‐Wellcome Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi

Locations

  • United Kingdom

  • United States

  • Malawi

  • Republic of South Korea

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Infectious Diseases (ID)

  • Central Nervous System (CNS)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Cerebral malaria

  • Diabetic retinopathy

  • Venous thrombosis

  • Malaria

Biomarkers

  • N/A

Drug/Treatment

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved